Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation

Annals of Intensive Care

Volumn 6, Issue 1, 2016, Pages

  Aubron, Cécile ^a,e,f   DePuydt, Joris ^b,c   Belon, François ^d   Bailey, Michael ^a   Schmidt, Matthieu ^a,g   Sheldrake, Jayne ^b   Murphy, Deirdre ^a,b   Scheinkestel, Carlos ^a,b   Cooper, D Jamie ^a,b   Capellier, Gilles ^d   Pellegrino, Vincent ^a,b   Pilcher, David ^a,b   McQuilten, Zoe ^a  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^e BREST UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ DE BREST   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Anticoagulation; Bleeding; Coagulopathy; Critically ill patients; Extra corporeal membrane oxygenation; Haemorrhage; Thromboembolic events

Indexed keywords

FIBRINOGEN CONCENTRATE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 8; TRANEXAMIC ACID;

ADULT; APACHE; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CANNULA; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; EAR BLEEDING; EPISTAXIS; EXTRACORPOREAL OXYGENATION; FEMALE; HEART TAMPONADE; HEMATOTHORAX; HOSPITAL MORTALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL ANALYSIS; THROAT BLEEDING; TREATMENT OUTCOME; VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION; VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION;

EID: 84990851935     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/s13613-016-0196-7     Document Type: Article

References (23)

1. Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med. 2009;35(12):2105–14.
2. Aubron C, Cheng AC, Pilcher D, Leong T, Magrin G, Cooper DJ, et al. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study. Crit Care. 2013;17(2):R73.
3. Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc J Aust Acad Crit Care Med. 2013;15(3):172–8.
4. Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Leger P, et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med. 2008;36(5):1404–11.
5. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, et al. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA. 2009;302(17):1888–95.
6. Murphy DA, Hockings LE, Andrews RK, Aubron C, Gardiner EE, Pellegrino VA, et al. Extracorporeal membrane oxygenation-hemostatic complications. Transfus Med Rev. 2015;29(2):90–101.
7. Hunt BJ, Parratt RN, Segal HC, Sheikh S, Kallis P, Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg. 1998;65(3):712–8.
8. Heilmann C, Geisen U, Beyersdorf F, Nakamura L, Benk C, Trummer G, et al. Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med. 2012;38(1):62–8.
9. Palatianos GM, Foroulis CN, Vassili MI, Astras G, Triantafillou K, Papadakis E, et al. A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit. Ann Thorac Surg. 2003;76(1):129–35.
10. Bembea MM, Annich G, Rycus P, Oldenburg G, Berkowitz I, Pronovost P. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2013;14(2):e77–84.
11. Paden ML, Conrad SA, Rycus PT, Thiagarajan RR. Extracorporeal life support organization registry report 2012. ASAIO J. 2013;59(3):202–10.
12. Rastan AJ, Lachmann N, Walther T, Doll N, Gradistanac T, Gommert JF, et al. Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO). Int J Artif Organs. 2006;29(12):1121–31.
13. Werho DK, Pasquali SK, Yu S, Donohue J, Annich GM, Thiagarajan RR, et al. Hemorrhagic complications in pediatric cardiac patients on extracorporeal membrane oxygenation: an analysis of the Extracorporeal Life Support Organization Registry. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2015;16(3):276–88.
14. Kasirajan V, Smedira NG, McCarthy JF, Casselman F, Boparai N, McCarthy PM. Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. Eur J Cardio Thorac Surg. 1999;15(4):508–14.
15. Extracorporeal Life Support Organization. ELSO Anticoagulation guideline. Ann Arbor, MI USA 2014. p. 17. Available on https://www.elso.org/Portals/0/Files/elsoanticoagulationguideline8-2014-table-contents.pdf.
16. Marasco SF, Lukas G, McDonald M, McMillan J, Ihle B. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ. 2008;17(Suppl 4):S41–7.
17. Kalbhenn J, Schmidt R, Nakamura L, Schelling J, Rosenfelder S, Zieger B. Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy. J Atheroscler Thromb. 2015;22(3):265–71.
18. Panigada M, Iapichino G, L’Acqua C, Protti A, Cressoni M, Consonni D, et al. Prevalence of “Flat-Line” thromboelastography during extracorporeal membrane oxygenation for respiratory failure in adults. ASAIO J. 2016;62(3):302–9.
19. Kalbhenn J, Wittau N, Schmutz A, Zieger B, Schmidt R. Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy. Perfusion. 2015.
20. Doymaz S, Zinger M, Sweberg T. Risk factors associated with intracranial hemorrhage in neonates with persistent pulmonary hypertension on ECMO. J Intensive Care. 2015;3(1):6.
21. Montan C, Johansson F, Hedin U, Wahlgren CM. Preoperative hypofibrinogenemia is associated with increased intraoperative bleeding in ruptured abdominal aortic aneurysms. Thromb Res. 2015;135(3):443–8.
22. Northrop MS, Sidonio RF, Phillips SE, Smith AH, Daphne HC, Pietsch JB, et al. The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2015;16(1):66–74.
23. Davis MC, Andersen NE, Johansson P, Andersen LW. Use of thromboelastograph and factor VII for the treatment of postoperative bleeding in a pediatric patient on ECMO after cardiac surgery. J Extra Corpor Technol. 2006;38(2):165–7.